About: Donna E. Davies

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Donna E. Davies Goto Sponge NotDistinct Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

Donna Elizabeth Davies (née Harrison) FMedSci is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease.

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal animal eukaryote scientist species schema:Person Scientist
rdfs:label	Donna E. Davies (es) Donna E. Davies (en)
rdfs:comment	Donna Elizabeth Davies (apellido de soltera: Harrison) es una bioquímica y profesora británica. Es docente de Células Respiratorias y Biología Molecular en la Universidad de Southampton. En 2003 fundó con dos de sus colegas la empresa , que desarrolla una droga de interferones beta para los tratamientos de pacientes con asma y enfermedad pulmonar obstructiva crónica. Davies es miembro de la Academia de Ciencias Médicas. (es) Donna Elizabeth Davies (née Harrison) FMedSci is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease. (en)
foaf:name	Donna Davies (en)
name	Donna Davies (en)
dct:subject	Welsh women scientists Living people Year of birth missing (living people) COVID-19 researchers Academics of the University of Southampton Alumni of the University of Wales Fellows of the Academy of Medical Sciences (United Kingdom)
Wikipage page ID	64643923 (xsd:integer)
Wikipage revision ID	1068143428 (xsd:integer)
Link from a Wikipage to another Wikipage	Welsh women scientists RuBisCO Epithelium Biochemistry United Kingdom University of Oxford University of Southampton University of Wales In vitro Innate immunity Living people Year of birth missing (living people) Common cold Rhinovirus Chronic obstructive pulmonary disease Enzyme Stephen Holgate (physician) Professor University spin-off COVID-19 pandemic COVID-19 researchers Fellow of the Academy of Medical Sciences Frances Ashcroft Reader (academic rank) Asthma Academics of the University of Southampton Alumni of the University of Wales Fellows of the Academy of Medical Sciences (United Kingdom) Biochemist Synairgen Respiratory disease PhD Oncology Molecular biology Microbial Interferon-beta Research fellow Respiratory tract Tissue engineering Medical Epithelial cell British Diabetic Association
Link from a Wikipage to an external page	http://www.worldcat.org/oclc/1110401218
sameAs	Donna E. Davies Donna E. Davies Donna E. Davies Donna E. Davies
thesis title	Ribulose 1,5 - bisphosphate carboxylase from microorganisms (en)
thesis url	http://www.worldcat.org/oclc/1110401218
thesis year	1979 (xsd:integer)
workplaces	University of Oxford University of Southampton (en)
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Cite_journal dbt:Ill dbt:Official_URL dbt:Post-nominals dbt:Reflist dbt:Short_description dbt:Infobox_scientist
alma mater	University of Wales
birth name	Donna Elizabeth Harrison (en)
fields	Epithelium Innate immunity Respiratory disease Tissue engineering
influences	Frances Ashcroft
known for	Synairgen
has abstract	Donna Elizabeth Davies (apellido de soltera: Harrison) es una bioquímica y profesora británica. Es docente de Células Respiratorias y Biología Molecular en la Universidad de Southampton. En 2003 fundó con dos de sus colegas la empresa , que desarrolla una droga de interferones beta para los tratamientos de pacientes con asma y enfermedad pulmonar obstructiva crónica. Davies es miembro de la Academia de Ciencias Médicas. (es) Donna Elizabeth Davies (née Harrison) FMedSci is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease. (en)
institution	University of Oxford

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3331 as of Sep 2 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 72 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software